{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:54:12Z","timestamp":1792659252601,"version":"4.5.0"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.cca.2014.08.039","type":"journal-article","created":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T10:04:08Z","timestamp":1409911448000},"page":"350-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":313,"special_numbering":"C","title":["Biomarkers of renal function, which and when?"],"prefix":"10.1016","volume":"438","author":[{"given":"Michael E.","family":"Wasung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakhmir S.","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Madero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cca.2014.08.039_bb0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF03262209","article-title":"Update on biomarkers of acute kidney injury: moving closer to clinical impact?","volume":"16","author":"Schiffl","year":"2012","journal-title":"Mol Diagn Ther"},{"issue":"3","key":"10.1016\/j.cca.2014.08.039_bb0010","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2165\/00003088-197904030-00003","article-title":"Use of serum creatinine concentrations to determine renal function","volume":"4","author":"Bjornsson","year":"1979","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"10.1016\/j.cca.2014.08.039_bb0015","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0002-9343(83)90873-2","article-title":"Renal functional reserve in humans. Effect of protein intake on glomerular filtration rate","volume":"75","author":"Bosch","year":"1983","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.cca.2014.08.039_bb0020","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1093\/ndt\/gfp428","article-title":"Creatinine as the gold standard for kidney injury biomarker studies?","volume":"24","author":"Waikar","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.cca.2014.08.039_bb0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00134-003-2078-3","article-title":"Defining acute renal failure: physiological principles","volume":"30","author":"Bellomo","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cca.2014.08.039_bb0030","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/ki.2012.208","article-title":"Acute kidney injury and chronic kidney disease: an integrated clinical syndrome","volume":"82","author":"Chawla","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.cca.2014.08.039_bb0035","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1681\/ASN.2007080837","article-title":"Acute kidney injury increases risk of ESRD among elderly","volume":"20","author":"Ishani","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cca.2014.08.039_bb0040","first-page":"1089","article-title":"Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease","volume":"76","author":"Lj","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.cca.2014.08.039_bb0045","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1097\/00003246-200209000-00016","article-title":"Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients","volume":"30","author":"Metnitz","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cca.2014.08.039_bb0050","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.294.7.813","article-title":"Acute renal failure in critically ill patients: a multinational, multicenter study","volume":"294","author":"Uchino","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2014.08.039_bb0055","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.1523-1755.2004.00927.x","article-title":"Spectrum of acute renal failure in the intensive care unit: The PICARD experience","volume":"66","author":"Mehta","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.cca.2014.08.039_bb0060","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000227785","article-title":"Early diagnosis of acute kidney injury: the promise of novel biomarkers","volume":"28","author":"Soni","year":"2009","journal-title":"Blood Purif"},{"issue":"1","key":"10.1016\/j.cca.2014.08.039_bb0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/CCM.0b013e3181bfb0b5","article-title":"Acute kidney injury in the intensive care unit: an update and primer for the intensivist","volume":"38","author":"Dennen","year":"2010","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.cca.2014.08.039_bb0070","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.03520807","article-title":"Urinary biomarkers for acute kidney injury: perspectives on translation","volume":"3","author":"Coca","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.cca.2014.08.039_bb0075","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1172\/JCI200422353","article-title":"Acute renal failure: definitions, diagnosis, pathogenesis and therapy","volume":"114","author":"Schrier","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2014.08.039_bb0080","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/ndt\/13.3.623","article-title":"Stimulation of tubular secretion of creatinine in health and in conditions associated with reduced nephron mass. Evidence for a tubular functional reserve","volume":"13","author":"Herrera","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cca.2014.08.039_bb0085","doi-asserted-by":"crossref","first-page":"402","DOI":"10.2215\/CJN.06960909","article-title":"Urine microscopy is associated with severity and worsening of acute kidney injury in hospitalized patients","volume":"5","author":"Perazella","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cca.2014.08.039_bb0090","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(05)74811-X","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery","volume":"365","author":"Mishra","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2014.08.039_bb0095","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/cc6089","article-title":"Urine neutrophil gelatinase associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study","volume":"11","author":"Zappitelli","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.cca.2014.08.039_bb0100","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/CCM.0b013e318169245a","article-title":"Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock","volume":"36","author":"Wheeler","year":"2008","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.cca.2014.08.039_bb0105","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.ajkd.2009.07.020","article-title":"Accuracy of neutrophil gelatinase associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis","volume":"54","author":"Haase","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.cca.2014.08.039_bb0110","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2215\/CJN.04240609","article-title":"Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance","volume":"5","author":"McIlroy","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cca.2014.08.039_bb0115","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1681\/ASN.2006080882","article-title":"Dual action of neutrophil gelatinase-associated lipocalin","volume":"18","author":"Schmidt-Ott","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cca.2014.08.039_bb0120","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1053\/j.ajkd.2008.05.018","article-title":"Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery","volume":"52","author":"Wagener","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cca.2014.08.039_bb0125","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1158\/1078-0432.CCR-07-1253","article-title":"Urinary biomarkers predict brain tumor presence and response to therapy","volume":"14","author":"Smith","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cca.2014.08.039_bb0130","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/ibd.20419","article-title":"Increased incidence of urinary matrix metalloproteinases as predictors of disease in pediatric patients with inflammatory bowel disease","volume":"14","author":"Manfredi","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cca.2014.08.039_bb0135","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1080\/00016340802464463","article-title":"Second trimester neutrophil gelatinase-associated lipocalin as a potential prediagnostic marker of preeclampsia","volume":"87","author":"D\u2019Anna","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.cca.2014.08.039_bb0140","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/ki.2011.21","article-title":"How to use biomarkers efficiently in acute kidney injury","volume":"79","author":"Lameire","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.cca.2014.08.039_bb0145","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/ki.2010.555","article-title":"Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function","volume":"79","author":"Endre","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.cca.2014.08.039_bb0150","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/cc12503","article-title":"Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury","volume":"17","author":"Kashani","year":"2013","journal-title":"Crit Care"},{"issue":"8","key":"10.1016\/j.cca.2014.08.039_bb0155","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1164\/rccm.201401-0077OC","article-title":"Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication","volume":"189","author":"Bihorac","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.cca.2014.08.039_bb0160","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/cc6192","article-title":"Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study","volume":"11","author":"Dent","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.cca.2014.08.039_bb0165","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1681\/ASN.2006030221","article-title":"Urinary N-acetyl-beta-(d) glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure","volume":"18","author":"Liangos","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.cca.2014.08.039_bb0170","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1053\/j.ajkd.2009.05.022","article-title":"Serum cystatin C for prediction of dialysis requirement or death in acute kidney injury: a comparative study","volume":"54","author":"Perianayagum","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cca.2014.08.039_bb0175","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2215\/CJN.09061209","article-title":"Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes","volume":"5","author":"Siew","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.cca.2014.08.039_bb0180","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1097\/CCM.0b013e318225761a","article-title":"Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit","volume":"39","author":"Doi","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cca.2014.08.039_bb0185","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.2215\/CJN.11261210","article-title":"Urinary biomarkers and renal recover in critically ill patients with renal support","volume":"6","author":"Srisawat","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cca.2014.08.039_bb0190","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-148-11-200806030-00003","article-title":"Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury","volume":"148","author":"Nickolas","year":"2008","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.cca.2014.08.039_bb0195","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/j.1600-6143.2006.01352.x","article-title":"Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation","volume":"6","author":"Parikh","year":"2006","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.cca.2014.08.039_bb0200","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s00467-007-0601-4","article-title":"NGAL is an early predictive biomarker of contrast-induced nephropathy in children","volume":"22","author":"Hirsch","year":"2007","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.cca.2014.08.039_bb0205","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1053\/j.ajkd.2003.10.040","article-title":"Urinary interleukin-18 is a marker of human acute tubular necrosis","volume":"43","author":"Parikh","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.cca.2014.08.039_bb0210","doi-asserted-by":"crossref","first-page":"F552","DOI":"10.1152\/ajprenal.00285.2002","article-title":"Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury","volume":"286","author":"Ichimura","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cca.2014.08.039_bb0215","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1681\/ASN.2007030325","article-title":"Shedding of the urinary biomarker kidney injury molecule-1 (KIM-1) is regulated by MAP kinases and juxtamembrane region","volume":"18","author":"Zhang","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cca.2014.08.039_bb0220","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1523-1755.2002.00433.x","article-title":"Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury","volume":"62","author":"Han","year":"2002","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.cca.2014.08.039_bb0225","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/13547500903067744","article-title":"Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass","volume":"14","author":"Liangos","year":"2009","journal-title":"Biomarkers"},{"key":"10.1016\/j.cca.2014.08.039_bb0230","first-page":"1","article-title":"Clinical practice guideline for acute kidney injury","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"9722","key":"10.1016\/j.cca.2014.08.039_bb0235","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0140-6736(09)62004-3","article-title":"Early recognition and prevention of chronic kidney disease","volume":"375","author":"James","year":"2010","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.cca.2014.08.039_bb0240","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrneph.2011.86","article-title":"Early detection of CKD: the benefits, limitations and effects on prognosis","volume":"7","author":"Levin","year":"2011","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"10.1016\/j.cca.2014.08.039_bb0245","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/ki.2010.550","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts","volume":"79","author":"Astor","year":"2011","journal-title":"Kidney Int"},{"issue":"16","key":"10.1016\/j.cca.2014.08.039_bb0250","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1001\/archinte.158.16.1743","article-title":"Chronic renal insufficiency: a diagnostic and therapeutic approach","volume":"158","author":"Rahman","year":"1998","journal-title":"Arch Intern Med"},{"issue":"23","key":"10.1016\/j.cca.2014.08.039_bb0255","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMra054415","article-title":"Assessing kidney function\u2014measured and estimated glomerular filtration rate","volume":"354","author":"Stevens","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.cca.2014.08.039_bb0260","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/MNH.0b013e32834ba210","article-title":"Creatinine-based formulae for estimating glomerular filtration rate: is it time to change to chronic kidney disease epidemiology collaboration equation?","volume":"20","author":"Madero","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.cca.2014.08.039_bb0265","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/clpt.2009.124","article-title":"Use of the MDRD study equation to estimate kidney function for drug dosing","volume":"86","author":"Stevens","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cca.2014.08.039_bb0270","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.cca.2014.08.039_bb0275","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1053\/j.ajkd.2010.02.337","article-title":"Estimating GFR using the CKD epidemiology collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions","volume":"55","author":"Levey","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cca.2014.08.039_bb0280","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0014-5793(88)80276-X","article-title":"Efficient production of native, biologically active human cystatin C by Escherichia coli","volume":"236","author":"Abrahamson","year":"1988","journal-title":"FEBS Lett"},{"issue":"11","key":"10.1016\/j.cca.2014.08.039_bb0285","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1373\/clinchem.2009.128397","article-title":"Cystatin C and cardiovascular risk","volume":"55","author":"Taglieri","year":"2009","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.cca.2014.08.039_bb0290","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/ajkd.2002.34487","article-title":"Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis","volume":"40","author":"Dharnidharka","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.cca.2014.08.039_bb0295","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1093\/ndt\/gfq621","article-title":"A comparison of cystatin C-and creatinine-based prediction equations for the estimation of glomerular filtration rate in black South Africans","volume":"26","author":"Van Deventer","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.cca.2014.08.039_bb0300","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1053\/j.ajkd.2013.03.027","article-title":"Update on cystatin C: incorporation into clinical practice","volume":"62","author":"Shlipak","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1016\/j.cca.2014.08.039_bb0305","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/ndt\/gfl073","article-title":"Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function","volume":"21","author":"Hojs","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cca.2014.08.039_bb0310","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/j.ajkd.2007.11.018","article-title":"Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD","volume":"51","author":"Stevens","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.cca.2014.08.039_bb0315","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.cca.2014.08.039_bb0320","doi-asserted-by":"crossref","first-page":"237","DOI":"10.7326\/0003-4819-145-4-200608150-00003","article-title":"Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease","volume":"145","author":"Shlipak","year":"2006","journal-title":"Ann Intern Med"},{"issue":"20","key":"10.1016\/j.cca.2014.08.039_bb0325","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa043161","article-title":"Cystatin C and the risk of death and cardiovascular events among elderly persons","volume":"352","author":"Shlipak","year":"2005","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.cca.2014.08.039_bb0330","doi-asserted-by":"crossref","first-page":"497","DOI":"10.7326\/0003-4819-142-7-200504050-00008","article-title":"Cystatin C concentration as a risk factor for heart failure in older adults","volume":"142","author":"Sarnak","year":"2005","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.cca.2014.08.039_bb0335","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1681\/ASN.2008030318","article-title":"Cystatin C associates with arterial stiffness in older adults","volume":"20","author":"Madero","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.cca.2014.08.039_bb0340","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1681\/ASN.2005040384","article-title":"Kidney function as a predictor of noncardiovascular mortality","volume":"16","author":"Fried","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cca.2014.08.039_bb0345","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1146\/annurev.med.48.1.489","article-title":"Nitric oxide synthase: role in the genesis of vascular disease","volume":"48","author":"Cooke","year":"1997","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.cca.2014.08.039_bb0350","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1073\/pnas.92.4.1137","article-title":"Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene","volume":"92","author":"von der Leyen","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2014.08.039_bb0355","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1172\/JCI115937","article-title":"Anti-atherogenic effects of l-arginine in the hypercholesterolemic rabbit","volume":"90","author":"Cooke","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2014.08.039_bb0360","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.ATV.16.1.44","article-title":"Regression or progression: dependency upon vascular nitric oxide","volume":"16","author":"Candipan","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.cca.2014.08.039_bb0365","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1440-1797.2007.00840.x","article-title":"Asymmetric dimethylarginine may be a missing link between cardiovascular disease and chronic kidney disease","volume":"12","author":"Ueda","year":"2007","journal-title":"Nephrology"},{"issue":"4","key":"10.1016\/j.cca.2014.08.039_bb0370","first-page":"377","article-title":"New pathways to renal damage: role of ADMA in retarding renal disease progression","volume":"23","author":"Ueda","year":"2010","journal-title":"J Nephrol"},{"issue":"8793","key":"10.1016\/j.cca.2014.08.039_bb0375","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","article-title":"Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure","volume":"339","author":"Vallance","year":"1992","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.cca.2014.08.039_bb0380","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.CIR.99.9.1141","article-title":"Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis","volume":"99","author":"Miyazaki","year":"1999","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.cca.2014.08.039_bb0385","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.2215\/CJN.11291210","article-title":"Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients","volume":"6","author":"Tripepi","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.cca.2014.08.039_bb0390","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1681\/ASN.2005020179","article-title":"Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study","volume":"16","author":"Fliser","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cca.2014.08.039_bb0395","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ki.1991.63","article-title":"Mechanisms of tubulointerstitial fibrosis","volume":"39","author":"Kuncio","year":"1991","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.cca.2014.08.039_bb0400","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00467-006-0244-x","article-title":"Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease","volume":"22","author":"Mitsnefes","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.cca.2014.08.039_bb0405","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/ndt\/gfs586","article-title":"Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric stages 3 and 4 chronic kidney disease","volume":"28","author":"Smith","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cca.2014.08.039_bb0410","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2215\/CJN.03530708","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease","volume":"4","author":"Bolignano","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.cca.2014.08.039_bb0415","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1053\/j.ajkd.2010.05.017","article-title":"Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study","volume":"56","author":"Warnock","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cca.2014.08.039_bb0420","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cca.2014.08.039_bb0425","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2014.08.039_bb0430","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2014.08.039_bb0435","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cca.2014.08.039_bb0440","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"issue":"23","key":"10.1016\/j.cca.2014.08.039_bb0445","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.cca.2014.08.039_bb0450","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0167-5699(90)90035-8","article-title":"Human monocyte chemoattractant protein-1 (MCP-1)","volume":"11","author":"Leonard","year":"1990","journal-title":"Immunol Today"},{"issue":"13","key":"10.1016\/j.cca.2014.08.039_bb0455","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1073\/pnas.87.13.5134","article-title":"Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells","volume":"87","author":"Cushing","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.cca.2014.08.039_bb0460","first-page":"819","article-title":"Monocyte chemotactic protein gene expression by cytokine-treated human retinal pigment epithelial cells","volume":"64","author":"Elner","year":"1991","journal-title":"Lab Invest"},{"issue":"4","key":"10.1016\/j.cca.2014.08.039_bb0465","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1046\/j.1523-1755.2000.00311.x","article-title":"Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy","volume":"58","author":"Wada","year":"2000","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.cca.2014.08.039_bb0470","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ki.1996.105","article-title":"Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis","volume":"49","author":"Wada","year":"1996","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.cca.2014.08.039_bb0475","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1046\/j.1523-1755.2000.00214.x","article-title":"Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy","volume":"58","author":"Banba","year":"2000","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.cca.2014.08.039_bb0480","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.ki.5000014","article-title":"Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice","volume":"69","author":"Chow","year":"2006","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.cca.2014.08.039_bb0485","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1523-1755.2004.00367.x","article-title":"Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury","volume":"65","author":"Chow","year":"2004","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.cca.2014.08.039_bb0490","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1210\/jc.2005-1718","article-title":"Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy","volume":"91","author":"Takebayashi","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.cca.2014.08.039_bb0495","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1182\/blood.V99.12.4457","article-title":"Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions","volume":"99","author":"Schober","year":"2002","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cca.2014.08.039_bb0500","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.arcmed.2006.06.002","article-title":"Serum monocyte chemoattractant protein-1 and monocyte adhesion molecules in type 1 diabetic patients with nephropathy","volume":"37","author":"Kiyici","year":"2006","journal-title":"Arch Med Res"},{"issue":"6","key":"10.1016\/j.cca.2014.08.039_bb0505","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1139\/o03-069","article-title":"The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology","volume":"81","author":"Leask","year":"2003","journal-title":"Biochem Cell Biol"},{"issue":"6","key":"10.1016\/j.cca.2014.08.039_bb0510","first-page":"1741","article-title":"Expression of connective tissue growth factor (CTGF\/CCN2) in breast cancer cells is associated with increased migration and angiogenesis","volume":"38","author":"Chien","year":"2011","journal-title":"Int J Oncol"},{"issue":"4","key":"10.1016\/j.cca.2014.08.039_bb0515","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1046\/j.1523-1755.2000.00301.x","article-title":"Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis","volume":"58","author":"Gupta","year":"2000","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.cca.2014.08.039_bb0520","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1523-1755.1998.00820.x","article-title":"Expression of connective tissue growth factor in human renal fibrosis","volume":"53","author":"Ito","year":"1998","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.cca.2014.08.039_bb0525","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/hep.510300425","article-title":"Expression of connective tissue growth factor in experimental rat and human liver fibrosis","volume":"30","author":"Paradis","year":"1999","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cca.2014.08.039_bb0530","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1523-1755.2003.00130.x","article-title":"Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: preliminary report","volume":"64","author":"Riser","year":"2003","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.cca.2014.08.039_bb0535","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2337\/diacare.29.01.06.dc05-1670","article-title":"Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy","volume":"29","author":"Nguyen","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2014.08.039_bb0540","first-page":"1","article-title":"Clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811400391X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811400391X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T03:01:23Z","timestamp":1538276483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000989811400391X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":108,"alternative-id":["S000989811400391X"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2014.08.039","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers of renal function, which and when?","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2014.08.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}